Cyndeo Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.97M | Buy |
4,866
+140
| +3% | +$56.8K | 0.12% | 161 |
|
|
2025
Q1 | $2.35M | Sell |
4,726
-1,573
| -25% | -$783K | 0.15% | 148 |
|
|
2024
Q4 | $3.28M | Buy |
6,299
+37
| +0.6% | +$19.2K | 0.22% | 118 |
|
|
2024
Q3 | $3.87M | Buy |
6,262
+1,586
| +34% | +$981K | 0.27% | 104 |
|
|
2024
Q2 | $2.59M | Buy |
4,676
+238
| +5% | +$132K | 0.2% | 134 |
|
|
2024
Q1 | $2.58M | Sell |
4,438
-364
| -8% | -$212K | 0.21% | 133 |
|
|
2023
Q4 | $2.55M | Buy |
4,802
+1,610
| +50% | +$854K | 0.24% | 116 |
|
|
2023
Q3 | $1.62M | Sell |
3,192
-4,943
| -61% | -$2.5M | 0.17% | 140 |
|
|
2023
Q2 | $4.24M | Buy |
8,135
+1,132
| +16% | +$591K | 0.44% | 66 |
|
|
2023
Q1 | $4.04M | Buy |
7,003
+1,100
| +19% | +$634K | 0.44% | 70 |
|
|
2022
Q4 | $3.25M | Buy |
+5,903
| New | +$3.25M | 0.38% | 88 |
|